Explorando una nueva perspectiva de las Candida no albicans: Su microbiología, epidemiología, patogenicidad, respuesta inmune y resistencia antifúngica.
Year: 2025
Type: article
Abstract: Non-albicans Candida (NAC) species are a group of opportunistic fungi that cause increasingly frequent infections in humans. These infections can have a significant clinical impact on hospital services, as they are often difficult to treat and may lead to severe complications. The epidemiology of NAC infections, such as Candida glabrata, Candida tropicalis, Candida krusei, Candida parapsilosis, Candida auris, and Candida guilliermondii, varies according to geographic location, and an increase in the incidence of these infections has been observed compared with C. albicans. Various biological factors contribute to their pathogenesis, including morphological changes in response to cellular stress, as well as the secretion of hydrolytic and antioxidant enzymes that promote survival and adaptation to different host microenvironments. The immune system plays a fundamental role in controlling infection through the recognition of fungal antigens, which activates innate and adaptive immune responses for the elimination of NAC species. The management of these infections involves the use of antifungal drugs, such as azoles or echinocandins; however, resistance mechanisms mediated by mutations have led to the failure of many pharmacotherapeutic treatments. Despite their significant clinical relevance, the existing literature on NAC species is fragmented, and many comprehensive studies are outdated. Therefore, this article presents an updated review of the literature on the microbiology, epidemiology, pathogenicity, immune response, and antifungal resistance of clinically relevant NAC species.
Source: Salutem Scientia Spiritus
Institution: Pontificia Universidad Javeriana
Language: Spanish
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7215451684
